Keith W. Pfeil - Aug 19, 2021 Form 4/A - Amendment Insider Report for GLOBUS MEDICAL INC (GMED)

Role
SVP, Chief Financial Officer
Signature
/s/ Kelly G. Huller, Attorney-in-Fact
Stock symbol
GMED
Transactions as of
Aug 19, 2021
Transactions value $
-$22,058
Form type
4/A - Amendment
Date filed
2/6/2023, 03:43 PM
Date Of Original Report
Aug 23, 2021
Previous filing
Aug 3, 2021
Next filing
Jan 31, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GMED Class A Common Stock Options Exercise $41.4K +833 $49.65 833 Aug 19, 2021 Direct F1
transaction GMED Class A Common Stock Sale -$63.4K -833 -100% $76.13 0 Aug 19, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GMED Stock Option (Right to Buy Class A Common Stock) Options Exercise $0 -833 -4% $0.00 20K Aug 19, 2021 Class A Common Stock 833 $49.65 Direct F1, F3, F4
transaction GMED Stock Option (Right to Buy Class A Common Stock) Options Exercise $0 0 0% $0.00* 24.2K Aug 19, 2021 Class A Common Stock 0 $53.27 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The original Form 4, filed on August 23, 2021, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a sale that occurred on August 19, 2021 at an exercise price of $53.27 when in fact such options were exercised at a price of $49.65.
F2 This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.
F3 These options were granted on September 3, 2019 and are fully vested.
F4 The original Form 4, filed on August 23, 2021, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a transaction that occurred on August 19, 2021 as exercising a total of 833 options granted on January 22, 2020 when in fact such options were granted on September 3, 2019. As a result of this administrative error, the number of derivative securities beneficially owned by the reporting person following the corrected transaction reflects an increase by 833 in the number of options granted in 2020 and a decrease by 833 in the number of options granted in 2019.
F5 These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.